Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study

✍ Scribed by Dana M. Chase; Michael W. Sill; Bradley J. Monk; Mark D. Chambers; Kathleen M. Darcy; Ernest S. Han; Barbara J. Buening; Joel I. Sorosky; John P. Fruehauf; Robert A. Burger

• Book ID: 118506662
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 842 KB
• Volume: 126
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2012.06.002